Asleep at the wheel: Pharmacy practice research advocacy and knowledge translation by Canadian pharmacy organizations

Canadian Pharmacists Journal

Volumn 143, Issue 2, 2010, Pages

  Truong, Kalena ^a,b   Rosenthal, Meagen ^b   Tsuyuki, Ross T ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; FOLLOW UP; HEALTH SURVEY; HUMAN; HYPERTENSION; MEDICAL SOCIETY; PATIENT CARE; PHARMACY; POLITICS; PROFESSIONAL PRACTICE; TIME;

EID: 77949703207     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.3821/1913-701X-143.2.78     Document Type: Article

References (24)

1. Task Force on a Blueprint for Pharmacy. Blueprint for pharmacy: the vision for pharmacy. Ottawa (ON): Canadian Pharmacists Association; 2008.
2. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Int Med 2002;162:1149-55.
3. McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists - Hypertension (SCRIP-HTN). Arch Intern Med 2008;168:2355-61.
4. Taylor J, Semchuk W, Neubauer S, et al. Patient satisfaction with a smoking cessation program in community pharmacies. Can Pharm J 2003;136:30-4.
5. Bungard TJ, Archer SL, Hamilton P, et al. Bringing the benefi ts of anticoagulation management services to the community: Alberta program may serve as a model of care. Can Pharm J 2006;139:58-63.
6. Chan P, Grindrod KA, Bougher D, et al. A systematic review of remuneration systems for clinical pharmacy care services. Can Pharm J 2008;141:102-12.
7. Canadian Institutes of Health Research. More about knowledge translation at CIHR. Available: www.cihr-irsc. gc.ca/e/39033.html (accessed June 3, 2009).
8. Montague T. Patients fi rst: closing the health care gap in Canada. Toronto (ON): John Wiley & Sons Canada Ltd.; 2004. p. 35-42.
9. Roberts AS, Benrimoj SI, Chen TF, et al. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm 2005;1:546-64.
10. Straus SE, Tetroe J, Graham I. Defi ning knowledge translation. CMAJ 2009;181:165-8.
11. Grimshaw JM, Thomson MA. What have new efforts to change professional practice achieved? Cochrane Effective Practice and Organization of Care Group. J R Soc Med 1998;91 Suppl 35:20-5.
12. Schwandt TA. Dictionary of qualitative inquiry. Thousand Oaks (CA): Sage Publications; 2001.
13. Estabrooks CA, Derksen L, Winther C, et al. The intellectual structure and substance of the knowledge utilization fi eld: a longitudinal author co-citation analysis, 1945 to 2004. Implement Sci 2008;3:49.
14. Estabrooks CA, Winther C, Derksen L. Mapping the fi eld: a bibliometric analysis of the research utilization literature in nursing. Nurs Res 2004;53:293-303.
15. Macdonald M, Regan S, Davidson H, et al. Knowledge translation to advance the nurse practitioner role in British Columbia: researchers and decision-makers conduct policy-relevant research to guide legislative and regulatory development and the design of a nurse practitioner education program. Healthc Policy 2006;1:80-9.
16. Zillich AJ, Sutherland JM, Kumbera PA, et al. Hypertension Outcomes through blood pressure Monitoring and Evaluation by pharmacists (HOME study). J Gen Intern Med 2005;20:1091-6.
17. Chabot I, Moisan J, Grégoire JP, et al. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003;37:1186-93.
18. Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med 2008;23:1966-72.
19. Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
20. McLean DL, Simpson SH, McAlister FA, et al. Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies. Can J Cardiol 2006;22:855-60.
21. Joffres MR, Hamet P, MacLean DR, et al. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001;14:1099-105.
22. Task Force on a Blueprint for Pharmacy. Blueprint for pharmacy: implementation plan. Ottawa (ON): Canadian Pharmacists Association; 2009.
23. Lavis JN, Robertson D, Woodside JM, et al. How can research organizations more effectively transfer research knowledge to decision makers? Milbank Q 2003;81:171-2, 221-48.
24. Tsuyuki RT, Schindel TJ. Changing pharmacy practice: the leadership challenge. Can Pharm J 2008;141:174-80.